Details of issuance or disposal
Monthly Status of Conversions and Exercises of the Series 1 Unsecured Convertible Bonds with Stock Acquisition Rights through a Third-Party Allotment (with a Conversion Price Adjustment Clause) and Series 2 Stock Acquisition Rights (with an Exercise Price Adjustment Clause)
Shares delivered during the month: 3,432,250 new shares and 0 transferred treasury shares. Shares delivered during the month in connection with the Series 2 stock acquisition rights: 0 new shares and 0 transferred treasury shares
The lower thin line represents the existing number of shares to which these shares will be added.
Conversion and exercise ratio subject to the conversion and exercise restrictions: 4.66% (3,432,250 shares delivered / 73,690,348 listed shares outstanding as of the payment date for the issuance)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
| Item | Details |
|---|---|
| Type of issuance or disposal | Monthly Status of Conversions and Exercises of the Series 1 Unsecured Convertible Bonds with Stock Acquisition Rights through a Third-Party Allotment (with a Conversion Price Adjustment Clause) and Series 2 Stock Acquisition Rights (with an Exercise Price Adjustment Clause) |
| Number of shares to be issued or disposed of | Shares delivered during the month: 3,432,250 new shares and 0 transferred treasury shares. Shares delivered during the month in connection with the Series 2 stock acquisition rights: 0 new shares and 0 transferred treasury shares |
| Intended allottee | EVO FUND (the allottee of the Series 1 Unsecured Convertible Bonds with Stock Acquisition Rights and Series 2 Stock Acquisition Rights) |
| Dilution Rate | Conversion and exercise ratio subject to the conversion and exercise restrictions: 4.66% (3,432,250 shares delivered / 73,690,348 listed shares outstanding as of the payment date for the issuance) |
| Total number of issued shares | 78,200,914 shares (as of the end of the month preceding the month covered) → Not disclosed |
| Exercise price | Series 2 stock acquisition rights: Not disclosed (no exercises during the month covered). Conversion prices of the Series 1 unsecured convertible bonds with stock acquisition rights: ¥87, ¥78, ¥74 and ¥76 (by conversion date) |
| Number of Stock Acquisition Rights | Series 2 stock acquisition rights: 593,779 issued, with 593,779 remaining unexercised at month-end (59,377,900 shares) |
| Procedures under the Corporate Code of Conduct | Report on compliance with the conversion and exercise limits under Article 434 of the Listing Regulations |
| Most recent equity financing | Issued on 3 August 2026: Series 1 unsecured convertible bonds with stock acquisition rights and Series 2 stock acquisition rights allocated to EVO FUND (the amount at issuance is Not disclosed in this document) |
Items this document does not state (19)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly status of conversions and exercises.